Pain News and Research

Latest Pain News and Research

New evidence-based guidelines for prevention, treatment of POAF

The American Association for Thoracic Surgery has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation (POAF) and flutter for thoracic surgical procedures.

23 Sep 2014

Pilot study shows benefits of psychoeducational wellness program in MS people

Kessler researchers have published a pilot study showing the benefits of a 10-week psychoeducational wellness program in people with multiple sclerosis (MS). Improvements were seen in mood, overall mental health, perceived stress, and pain.

23 Sep 2014

Single-family room environment can optimize care for preterm infants

The prevalence of preterm birth - the birth of an infant prior to 37 weeks of pregnancy - is a significant health problem that has increased over the past two decades. According to the Centers for Disease Control and Prevention, preterm birth affects nearly 500,000 babies each year, or one of every eight born in the U.S. While medical care has improved survival rates for preterm infants, questions remain about ways to positively impact the neurodevelopmental outcomes of preterm infants.

23 Sep 2014

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Elusys Therapeutics, Inc., a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204).

23 Sep 2014

Neuropathic pain phenotype identified in knee osteoarthritis

Some patients with knee osteoarthritis may experience neuropathic-like symptoms associated with central pain processing, reflecting a discrete phenotype, study findings suggest.

22 Sep 2014

EYLEA Injection gets approval in Japan for treatment of myopic CNV

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEA (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV).

22 Sep 2014

UVA earns national award for enhancing care for heart attack patients

The University of Virginia Health System has earned a national award from the American College of Cardiology for enhancing care for heart attack patients.

21 Sep 2014

Researchers identify control mechanism for mood disorders

Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."

19 Sep 2014

Health law's ripple effects on hospitals, schools, uninsured

The Kansas City Star reports that some uninsured patients fall through the cracks as hospitals cut back on charity care to persuade people to sign up for coverage. Some schools, meanwhile, are turning to private substitutes to avoid having to pay for their health coverage next year. In Colorado, Denver Health is back in the black, partly due to a dramatic decrease in uninsured patients.

19 Sep 2014

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked by ear pain, pressure and dulled hearing.

18 Sep 2014

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).

18 Sep 2014

Benefits and risks of hatha yoga for people with bipolar disorder

Right now no one can say whether yoga provides clinical benefits to people with bipolar disorder, but in a new article in the Journal of Psychiatric Practice, researchers report survey responses they gathered from scores of people with the condition who practice yoga. What the collective testimony suggests is that yoga can be a substantial help, but it sometimes carries risks, too.

18 Sep 2014

Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor could be a useful biomarker for the diagnosis of overactive bladder and a predictive biomarker to help guide treatment, Chinese researchers believe.

17 Sep 2014

Fat mass contributes to musculoskeletal pain risk

People with high fat mass could be at an increased risk of musculoskeletal pain, say researchers.

17 Sep 2014

Catecholamine polymorphism influences opioid use

The catechol-O-methyltransferase rs4680 single nucleotide polymorphism could affect postoperative opioid consumption, study findings show.

17 Sep 2014

Johns Hopkins researchers adopt "Just-in-Time" process to reduce patient wait times

Using a pain clinic as a testing ground, researchers at Johns Hopkins have shown that a management process first popularized by Toyota in Japan can substantially reduce patient wait times and possibly improve the teaching of interns and residents.

17 Sep 2014

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding a common epilepsy drug to a morphine regimen can result in better pain control with fewer side effects. Moreover, the combination can reduce the dosage of the opioid needed to be effective, according to a team of pain researchers at Indiana University.

17 Sep 2014

Covered California unveils ad campaign, awards $14.6M for outreach

And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.

17 Sep 2014

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Prescription drug abuse is an extremely complex problem with no single solution. For example, the very same medications that are so critical for alleviating pain in legitimate patients could easily be diverted and misused by other people.

16 Sep 2014

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.

16 Sep 2014

Pain News and Research

Latest Pain News and Research

New evidence-based guidelines for prevention, treatment of POAF

Pilot study shows benefits of psychoeducational wellness program in MS people

Single-family room environment can optimize care for preterm infants

Elusys completes phase 3 clinical program of obiltoxaximab in healthy adult volunteers

Neuropathic pain phenotype identified in knee osteoarthritis

EYLEA Injection gets approval in Japan for treatment of myopic CNV

UVA earns national award for enhancing care for heart attack patients

Researchers identify control mechanism for mood disorders

Health law's ripple effects on hospitals, schools, uninsured

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Benefits and risks of hatha yoga for people with bipolar disorder

Urinary nerve growth factor shows diagnostic value

Fat mass contributes to musculoskeletal pain risk

Catecholamine polymorphism influences opioid use

Johns Hopkins researchers adopt "Just-in-Time" process to reduce patient wait times

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Covered California unveils ad campaign, awards $14.6M for outreach

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in